2019

1. Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy

   Hepatology, Vol. 70, Núm. 4, pp. 1246-1261

2. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

   British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800